Physician profile
Kelsey E Johnston
NPI 1174039341
$1,437.78
in general payments reported to CMS, 2019-2025
20 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $175 · 2022: $401 · 2023: $256 · 2024: $200 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $861.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $361.59 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $178.46 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $145.07 | 2022-2025 | |
| Organon LLC | $105.36 | 2021-2025 | Jada System, Nexplanon |
| Astellas Pharma US INC | $104.48 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $83.26 | 2024-2025 | Paragard T 380a |
| Daiichi Sankyo INC. | $82.76 | 2021 | |
| Myriad Women'S Health, INC. | $59.43 | 2023 | Myrisk |
| Sumitomo Pharma America, INC. | $49.76 | 2025 | Myfembree |
| Myovant Sciences INC. | $40.29 | 2022 | |
| Evofem Biosciences, INC. | $33.35 | 2021-2023 | Phexxi |
| Ethicon US, LLC | $32.85 | 2023 | Harmonic, Stratafix |
| Millicent US INC | $30.14 | 2024-2025 | Intrarosa, Femlyv, Femring |
| Exeltis, USA INC. | $28.08 | 2022-2023 | Slynd |
| Biogen, INC. | $25.82 | 2025 | Zurzuvae |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $19.80 | 2022 | |
| Hologic Sales and Service, LLC | $17.54 | 2024 | Novasure, Myosure Tissue Removal Device |
| Gynesonics, INC. | $15.89 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Aspira Women'S Health INC | $12.20 | 2024 | Ova1 |
| Therapeuticsmd, INC. | $11.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelsey Johnston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.